TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
Active, not recruiting · NCT01918683 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Not applicable | 2026-01-29 | NCT01918683 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
| Loyola University | 27 |
| Oregon Health and Science University | 244 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | United States | 47 |
| Loyola University Medical Center | Maywood | United States | 258 |
| Oregon Health & Science University | Portland | United States | 261 |